Form 483 · FEI 3008322822

Form 483 issued January 31, 2025

Inspection
Jan 23 – Jan 31, 2025
Observations
2
Pages
3
FEI number
3008322822

In short: On January 31, 2025, FDA issued a Form 483 with 2 observations to an FDA-inspected site (FEI 3008322822) after an inspection that ran Jan 23 – Jan 31, 2025. The investigators were Thai D. Truong and Travis S. Bradley. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Observations span 1 system, led by quality system.

Quality system1
Other1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Discrepancy and failure investigations related to manufacturing were not expanded to…

  2. 02

    Procedures for the acceptance and rejection of components and materials utilized within drug substance…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at an FDA-inspected site?

FDA listed 2 observations on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected an FDA-inspected site?

Thai D. Truong and Travis S. Bradley are named on this Form 483, for the inspection of Jan 23 – Jan 31, 2025. Each investigator has a profile showing what they cite most.

When was an FDA-inspected site inspected by FDA?

The inspection ran Jan 23 – Jan 31, 2025, and the Form 483 is dated January 31, 2025.

How do I get the full Form 483 for an FDA-inspected site?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free